Related Experiment Video
Updated: Jul 8, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Prevalence of hepatitis C in the general population in the Netherlands
S Slavenburg1, F M Verduyn-Lunel, J T Hermsen
1Department of Medicine, Division of Gastroenterology & Hepatology, Radboud University Nijmegen Medical Centre, the Netherlands. S.Slavenburg@mdl.umcn.nl
Insights
The prevalence of Hepatitis C Virus (HCV) in the general Dutch population is estimated at 0.2%. This study assessed HCV antibodies in a sample from the Netherlands, finding a low prevalence.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Hepatitis C Virus (HCV) is a blood-borne pathogen with high prevalence in specific risk groups.
- The prevalence of HCV in the general Dutch population was previously unknown.
- Screened blood donors in the Netherlands show a very low HCV prevalence (0.0169%).
Purpose of the Study:
- To estimate the prevalence of Hepatitis C Virus (HCV) in a general population sample.
- The study focused on an urbanized region in the Netherlands.
- To provide data on HCV epidemiology in a non-risk population.
Main Methods:
- Random selection of 2200 EDTA blood samples for biochemical analysis.
- A three-step HCV antibody testing approach was employed.
- Enzyme immunoassay screening, followed by a second immunoassay for confirmation, and Line Probe Assay for genotyping.
Main Results:
- Four individuals (0.2%) tested positive for HCV antibodies.
- Serological results were confirmed with a second specific immunoassay.
- Hepatitis C Virus RNA, genotype 1b, was detected in two individuals.
Conclusions:
- The estimated prevalence of Hepatitis C Virus (HCV) in the sampled Dutch population is 0.2%.
- This finding aligns with previous prevalence estimates in the Netherlands.
- The study contributes to understanding HCV epidemiology in the general population.
Background:
Chronic hepatitis C virus (HCV) is transmitted by blood-blood contact and this leads to high HCV prevalence in risk populations such as haemophilia patients and intravenous drug users. The prevalence in the general Dutch population is unknown, although it appears to be very low in screened blood donors (0.0169%).
Aim:
The objective of this study is to estimate the prevalence of HCV in a general population sample living in an urbanized region in the Netherlands.
Methods:
We randomly selected 2200 EDTA blood samples that had been submitted for analysis of biochemical parameters to a regional servicing laboratory for general practitioners (SHO, Arnhem/Nijmegen, the Netherlands). HCV antibody testing was performed using a three-step approach. For initial screening, an enzyme immunoassay (Bioelisa HCV 4.0, Biokit, Spain) was used. Positive samples were subjected to a second, microparticle enzyme-linked immunoassay (AxSYM HCV version 3.0, Abbott laboratories, IL , USA). Genotypes were determined by Line Probe Assay.
Results:
A total of four persons (two females, two males) (0.2%) tested positive for HCV antibodies. The average OD/cut-off ratio of the screening assay was 2.9 (range 1.0 to 7.3) and serological findings were confirmed using a specific second immunoassay. HCV RNA (genotype 1b) was found in the sera of two persons.
Conclusion:
The HCV prevalence in our sample of the Dutch population was 0.2% which accords with earlier estimates from prevalence studies in the Netherlands.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Genital Herpes
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Hepatic Drug Excretion: Influencing Factors